[Prophylactic attempts in Rh-sensitized pregnant women with progesterone, vitamin K and antihistaminics].
D018926:Anti-Allergic Agents; D000933:Antifibrinolytic Agents; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005333:Fetus; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy / Q000097:blood; D011374:Progesterone / Q000627:therapeutic use*; D012204:Rh-Hr Blood-Group System; D014812:Vitamin K / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000933:Antifibrinolytic Agents; D006634:Histamine H1 Antagonists; D012204:Rh-Hr Blood-Group System; D014812:Vitamin K; D011374:Progesterone
ANTIHISTAMINICS/therapeutic use; ERYTHROBLASTOSIS, FETAL/prevention and control; PREGNANCY/blood in; PROGESTERONE/therapeutic use; RH FACTORS; VITAMIN K/therapeutic use
Uber Prophylaxeversuche bei Rh-sensibilisierten Schwangeren mit Progesteron, Vitamin K und Antihistaminika.